CN101912540A - Medicament for treating cerebral infarction - Google Patents
Medicament for treating cerebral infarction Download PDFInfo
- Publication number
- CN101912540A CN101912540A CN201010260245XA CN201010260245A CN101912540A CN 101912540 A CN101912540 A CN 101912540A CN 201010260245X A CN201010260245X A CN 201010260245XA CN 201010260245 A CN201010260245 A CN 201010260245A CN 101912540 A CN101912540 A CN 101912540A
- Authority
- CN
- China
- Prior art keywords
- medicine
- medicament
- cerebral infarction
- radix
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a medicament for treating cerebral infarction, which is prepared from agkistrodon halys, red ginseng, tall gastrodia tuber, astragalus, Chinese angelica, root of red-rooted salvia, earthworm, szechuan lovage rhizome and leech serving as raw materials. The medicament can be prepared into various formulations applied clinically. In the prescription of the invention, the medicament has the advantages of collaboration among monarch, minister, assistant and conductant medicaments, diagnosis and treatment based on overall analysis of the illness and the patient condition, effect of activating blood and reinforcing qi, good curative effect on cardiovascular and cerebrovascular diseases such as the cerebral infarction and the like, no toxic or side effects and safe and reliable clinical application.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of cerebral infarction, particularly relating to a kind of is the medicine of the treatment cerebral infarction of crude drug preparation with Chinese medicine.
Background technology
Cardiovascular and cerebrovascular disease is the particularly commonly encountered diseases of middle-aged and elderly people health of a kind of serious threat mankind, even use most advanced, perfect at present treatment means, still can have the cerebrovascular accident survivor life more than 50% not take care of oneself fully.Cardiovascular and cerebrovascular disease has the characteristics of " sickness rate height, mortality rate height, disability rate height, relapse rate height, complication are many "-" four is high by more than one ", and at present, China cardiovascular and cerebrovascular disease patient has surpassed 2.7 hundred million people.It is more to be used to the Western medicine kind of bringing down a fever at present, the Agkistrodon halys antithrombotic pill is a kind of medicine that is widely used in clinical cardiovascular and cerebrovascular disease, and having good mass effect, its dosage form, raw material mass mixture ratio, preparation method etc. also require further study carries out perfect with clinical trial.
Summary of the invention
The present invention aims to provide that a kind of therapeutic effect is good, cost is low, the medicine of the treatment cardiovascular and cerebrovascular disease of no obvious toxic-side effects.
Medicine of the present invention is prepared by following materials of weight proportions medicine:
Agkistrodon halys 10-16 Radix Ginseng Rubra 8-11 Rhizoma Gastrodiae 8-11
Radix Astragali 8-12 Radix Angelicae Sinensis 8-11 Radix Salviae Miltiorrhizae 7-15
Pheretima 8-12 Rhizoma Chuanxiong 10-16 Hirudo 1-1.6.
The optimization proportioning of each component is in the medicine of the present invention:
Agkistrodon halys 15 Radix Ginseng Rubra 10 Rhizoma Gastrodiaes 10
The Radix Astragali 10 Radix Angelicae Sinensis 10 Radix Salviae Miltiorrhizaes 10
Pheretima 10 Rhizoma Chuanxiongs 15 Hirudos 1.5.
The raw material of above-mentioned each component can be made the various medicaments of clinical practice.
The concocting process of each medicine is as follows:
Agkistrodon halys decaptitates, and bones, and removes internal organs, removes the Serpentis squama, and airing is pulverized, and is used as medicine; Radix Astragali marmite parching to brown is gone into locust honey, reaches yellow fragrant plant close processing to good comprehensively, pulverizes, and is used as medicine; Hirudo is used the marmite parching to brown, goes into peak honey, and Hirudo is close processing to good comprehensively, and pulverizing is used as medicine; Pheretima catches spring and autumn, in time cuts open the belly, and removes internal organs and silt, cleans, and shines thousand, and pulverizing is used as medicine; Fructus Cannabis is used the winter fiber crops more, cleans immediately after excavating, and steams thoroughly, and it is dry to open wide low temperature thousand, pulverizes, and is used as medicine.
The pharmacology of each medicine of the present invention is:
The side separates: the fervent Serpentis of monarch drug has and walks to scurry meridians, invigorating blood circulation billows, the effect of coat wind relieving convulsion.
Ministerial drug: Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Hirudo have that collaborative monarch drug is invigorated blood circulation, the function of blood stasis dispelling.
Adjuvant drug: Pheretima, Rhizoma Gastrodiae assistant Agkistrodon halys are removed vasospasm.
Messenger drug: Radix Ginseng Rubra, the Radix Astragali, Mel can QI invigorating, reply the human righteousness, and the strong excessively property of medicine of opposing monarch drug relaxes monarch drug toxicity.
In the prescription of the present invention, monarch cooperative cooperating, dialectical executing are controlled, and invigorate blood circulation and hold up gas, and the cerebral infarction cardiovascular and cerebrovascular disease of waiting indefinitely is had better curative effect.
Clinical effectiveness for checking medicine of the present invention, use medicine of the present invention in Changzhi City second the People's Hospital surplus 1996-2009 clinical treatment cardiovascular and cerebrovascular disease patients 500 example, total effective rate 90.2%, clinical test results proves, effect of drugs of the present invention is obvious, and have no side effect, clinical practice is safe and reliable.
The specific embodiment
Following embodiment is in order to the explanation technical solution of the present invention, but do not constitute restriction to technical solution of the present invention.
Embodiment 1:
Prepare raw material according to following weight:
Agkistrodon halys 1.5kg, Radix Ginseng Rubra 1kg, Rhizoma Gastrodiae 1kg, Radix Astragali 1kg, Radix Angelicae Sinensis 1kg, Radix Salviae Miltiorrhizae 1kg, Pheretima 1kg, Rhizoma Chuanxiong 1.5kg, Hirudo 0.15kg.
With the each component of above-mentioned quality proportioning through following concocting process:
Agkistrodon halys decaptitates, and bones, and removes internal organs, removes the Serpentis squama, and airing is pulverized, and is used as medicine; Radix Astragali marmite parching to brown is gone into locust honey, reaches yellow fragrant plant close processing to good comprehensively, pulverizes, and is used as medicine; Hirudo is used the marmite parching to brown, goes into peak honey, and Hirudo is close processing to good comprehensively, and pulverizing is used as medicine; Pheretima catches spring and autumn, in time cuts open the belly, and removes internal organs and silt, cleans, and shines thousand, and pulverizing is used as medicine; Fructus Cannabis is used the winter fiber crops more, cleans immediately after excavating, and steams thoroughly, and it is dry to open wide low temperature thousand, pulverizes, and is used as medicine.
The medicament mixed of concocting after pulverizing is made pill.
Claims (2)
1. medicine for the treatment of cerebral infarction, it is characterized in that: it is to be prepared by following materials of weight proportions medicine:
Agkistrodon halys 10-16 Radix Ginseng Rubra 8-11 Rhizoma Gastrodiae 8-11
Radix Astragali 8-12 Radix Angelicae Sinensis 8-11 Radix Salviae Miltiorrhizae 7-15
Pheretima 8-12 Rhizoma Chuanxiong 10-15 Hirudo 1-1.6.
2. the medicine of treatment cerebral infarction according to claim 1 is characterized in that: it is to be prepared by following materials of weight proportions medicine:
Agkistrodon halys 15 Radix Ginseng Rubra 10 Rhizoma Gastrodiaes 10
The Radix Astragali 10 Radix Angelicae Sinensis 10 Radix Salviae Miltiorrhizaes 10
Pheretima 10 Rhizoma Chuanxiongs 15 Hirudos 1.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010260245XA CN101912540A (en) | 2010-08-20 | 2010-08-20 | Medicament for treating cerebral infarction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010260245XA CN101912540A (en) | 2010-08-20 | 2010-08-20 | Medicament for treating cerebral infarction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101912540A true CN101912540A (en) | 2010-12-15 |
Family
ID=43320287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010260245XA Pending CN101912540A (en) | 2010-08-20 | 2010-08-20 | Medicament for treating cerebral infarction |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101912540A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102441125A (en) * | 2011-11-30 | 2012-05-09 | 宋爱民 | Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae |
| CN105412519A (en) * | 2015-12-30 | 2016-03-23 | 郎立峰 | Traditional Chinese medicine preparation for treating cerebral infarction and preparation method thereof |
| CN109674947A (en) * | 2019-01-25 | 2019-04-26 | 龙步明 | A kind of Chinese herbal and crude drugs preparations for treating cerebral infarction |
| CN112263648A (en) * | 2020-11-14 | 2021-01-26 | 大连正源中医门诊部有限公司 | Traditional Chinese medicine for preventing and treating cerebral arterial thrombosis |
-
2010
- 2010-08-20 CN CN201010260245XA patent/CN101912540A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102441125A (en) * | 2011-11-30 | 2012-05-09 | 宋爱民 | Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae |
| CN102441125B (en) * | 2011-11-30 | 2014-01-15 | 宋爱民 | Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae |
| CN105412519A (en) * | 2015-12-30 | 2016-03-23 | 郎立峰 | Traditional Chinese medicine preparation for treating cerebral infarction and preparation method thereof |
| CN109674947A (en) * | 2019-01-25 | 2019-04-26 | 龙步明 | A kind of Chinese herbal and crude drugs preparations for treating cerebral infarction |
| CN112263648A (en) * | 2020-11-14 | 2021-01-26 | 大连正源中医门诊部有限公司 | Traditional Chinese medicine for preventing and treating cerebral arterial thrombosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112891399A (en) | Traditional Chinese medicine composition and application and preparation method thereof | |
| CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
| CN101912540A (en) | Medicament for treating cerebral infarction | |
| CN100493590C (en) | Astragalus leech collateral clearing capsule | |
| CN103417774B (en) | Traditional Chinese medicine and preparing method and application thereof | |
| CN101391081A (en) | Medicine composition for treating qi and blood derangement of essential hypertension and preparation method thereof | |
| CN101057922A (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN107913377A (en) | It is a kind of treat rheumatic disease harvest sub- wine and preparation method thereof | |
| AU783302B2 (en) | Composition of traditional chinese medicines for preventing and treating cerebrovascular disease | |
| CN101637536B (en) | Medicine for treating chronic sinusitis and preparation method thereof | |
| CN101422577B (en) | External traditional Chinese medicine for treating scald and burn and preparation method thereof | |
| CN101721479A (en) | Chinese herbal medicine preparation for treating rheumatalgia | |
| CN100534496C (en) | Chinese medicine for treating ischemic necrosis of femoral head | |
| CN104784398A (en) | Externally-applied ointment for treating stroke sequelae and preparation method thereof | |
| CN102302642A (en) | Medicament for treating chloasma and preparation method thereof | |
| CN103055273B (en) | Three-original ecology tracing stasis-clearing detoxification health traditional Chinese medicine and preparation method thereof | |
| CN102258699A (en) | Chinese patent medicament for treating cervical spondylosis and cranial nerve vascular diseases and preparation method thereof | |
| CN107281444B (en) | Analgesic pharmaceutical composition and preparation method and application thereof | |
| Chen | Herbology in Three Traditional Medicines for Acne | |
| Vasilenko | Prospects of Complementary Medicine in Prevention and Treatment of COVID-19: Phytotherapy as a Traditional Chinese Medicine and Ayurveda Technique | |
| CN104645247A (en) | Traditional Chinese medicine preparation for treating hepatolenticular degeneration and preparation method of traditional Chinese medicine preparation | |
| CN112618671A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation, preparation method and application | |
| CN103800809A (en) | Traditional Chinese medicinal preparation for treating liver diseases | |
| CN100364577C (en) | A medicine for treating gynecological disease | |
| CN102772594A (en) | Health-care medicinal liquor for controlling lumbar disc herniation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20101215 |